Rituximab therapy for IgA nephropathy
Crossref DOI link: https://doi.org/10.1038/nrneph.2016.188
Published Online: 2016-12-28
Published Print: 2017-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Floege, Jürgen
Text and Data Mining valid from 2016-12-28
Article History
First Online: 28 December 2016
Competing interests
: J.F. has received consultancy fees from Pharmalink, Sweden, and is a principal investigator in an Anthera-sponsored clinical trial in IgA nephropathy.